Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res July 1 2011 17 (13) 4187-4187;

CCR Translations

  • CCR Translations
    Getting Personal with Melanoma
    Helen Heslop
    Clin Cancer Res July 1 2011 17 (13) 4189-4191; DOI:10.1158/1078-0432.CCR-11-0841

CCR New Strategies

  • CCR New Strategies
    New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease
    Ramesh Rengan, Amit M. Maity, James P. Stevenson and Stephen M. Hahn
    Clin Cancer Res July 1 2011 17 (13) 4192-4199; DOI:10.1158/1078-0432.CCR-10-2760

Molecular Pathways

  • Molecular Pathways
    WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
    Philip C. De Witt Hamer, Shahryar E. Mir, David Noske, Cornelis J.F. Van Noorden and Tom Würdinger
    Clin Cancer Res July 1 2011 17 (13) 4200-4207; DOI:10.1158/1078-0432.CCR-10-2537

  • Molecular Pathways
    Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors
    Angela Brodie and Gauri Sabnis
    Clin Cancer Res July 1 2011 17 (13) 4208-4213; DOI:10.1158/1078-0432.CCR-10-2920

Review

  • Review
    Immune Recruitment and Therapeutic Synergy: Keys to Optimizing Oncolytic Viral Therapy?
    Jay D. Naik, Christopher J. Twelves, Peter J. Selby, Richard G. Vile and John D. Chester
    Clin Cancer Res July 1 2011 17 (13) 4214-4224; DOI:10.1158/1078-0432.CCR-10-2848

Perspective

  • Perspective
    Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
    Iris J.H. van Vlodrop, Hanneke E.C. Niessen, Sarah Derks, Marcella M.L.L. Baldewijns, Wim van Criekinge, James G. Herman and Manon van Engeland
    Clin Cancer Res July 1 2011 17 (13) 4225-4231; DOI:10.1158/1078-0432.CCR-10-3394

Human Cancer Biology

  • Human Cancer Biology
    Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
    David J. Andorsky, Reiko E. Yamada, Jonathan Said, Geraldine S. Pinkus, David J. Betting and John M. Timmerman
    Clin Cancer Res July 1 2011 17 (13) 4232-4244; DOI:10.1158/1078-0432.CCR-10-2660

  • Human Cancer Biology
    Primary Central Nervous System Lymphomas: A Validation Study of Array-Based Comparative Genomic Hybridization in Formalin-Fixed Paraffin-Embedded Tumor Specimens
    Esteban Braggio, Ellen Remstein McPhail, William Macon, M. Beatriz Lopes, David Schiff, Mark Law, Stephanie Fink, Debra Sprau, Caterina Giannini, Ahmet Dogan, Rafael Fonseca and Brian Patrick O'Neill
    Clin Cancer Res July 1 2011 17 (13) 4245-4253; DOI:10.1158/1078-0432.CCR-11-0395

  • Human Cancer Biology
    KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer
    Lilach Abramovitz, Tamar Rubinek, Hagai Ligumsky, Shikha Bose, Iris Barshack, Camila Avivi, Bella Kaufman and Ido Wolf
    Clin Cancer Res July 1 2011 17 (13) 4254-4266; DOI:10.1158/1078-0432.CCR-10-2749

  • Human Cancer Biology
    BORIS Binding to the Promoters of Cancer Testis Antigens, MAGEA2, MAGEA3, and MAGEA4, Is Associated with Their Transcriptional Activation in Lung Cancer
    Sheetal Bhan, Sandeep S. Negi, Chunbo Shao, Chad A. Glazer, Alice Chuang, Daria A. Gaykalova, Wenyue Sun, David Sidransky, Patrick K. Ha and Joseph A. Califano
    Clin Cancer Res July 1 2011 17 (13) 4267-4276; DOI:10.1158/1078-0432.CCR-11-0653

  • Human Cancer Biology
    Clinical Significance of miR-146a in Gastric Cancer Cases
    Ryunosuke Kogo, Koshi Mimori, Fumiaki Tanaka, Shizuo Komune and Masaki Mori
    Clin Cancer Res July 1 2011 17 (13) 4277-4284; DOI:10.1158/1078-0432.CCR-10-2866

  • Human Cancer Biology
    PLK1 Is Transcriptionally Activated by NF-κB during Cell Detachment and Enhances Anoikis Resistance through Inhibiting β-Catenin Degradation in Esophageal Squamous Cell Carcinoma
    De-Chen Lin, Yu Zhang, Qin-Jing Pan, Hai Yang, Zhi-Zhou Shi, Zhi-Hui Xie, Bo-Shi Wang, Jia-Jie Hao, Tong-Tong Zhang, Xin Xu, Qi-Min Zhan and Ming-Rong Wang
    Clin Cancer Res July 1 2011 17 (13) 4285-4295; DOI:10.1158/1078-0432.CCR-10-3236

  • Human Cancer Biology
    Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
    Jennifer Lohr, Thomas Ratliff, Andrea Huppertz, Yingzi Ge, Christine Dictus, Rezvan Ahmadi, Stefan Grau, Nobuyoshi Hiraoka, Volker Eckstein, Rupert C. Ecker, Thomas Korff, Andreas von Deimling, Andreas Unterberg, Philipp Beckhove and Christel Herold-Mende
    Clin Cancer Res July 1 2011 17 (13) 4296-4308; DOI:10.1158/1078-0432.CCR-10-2557

  • Human Cancer Biology
    MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin
    Tricia Nardiello, Achim A. Jungbluth, Anna Mei, Maurizio DiLiberto, Xiangao Huang, Ania Dabrowski, Valéria C.C. Andrade, Rebecca Wasserstrum, Scott Ely, Ruben Niesvizky, Roger Pearse, Morton Coleman, David S. Jayabalan, Nina Bhardwaj, Lloyd J. Old, Selina Chen-Kiang and Hearn Jay Cho
    Clin Cancer Res July 1 2011 17 (13) 4309-4319; DOI:10.1158/1078-0432.CCR-10-1820

  • Human Cancer Biology
    Integrated, Genome-Wide Screening for Hypomethylated Oncogenes in Salivary Gland Adenoid Cystic Carcinoma
    Chunbo Shao, Wenyue Sun, Marietta Tan, Chad A. Glazer, Sheetal Bhan, Xiaoli Zhong, Carole Fakhry, Rajni Sharma, William H. Westra, Mohammad O. Hoque, Christopher A. Moskaluk, David Sidransky, Joseph A. Califano and Patrick K. Ha
    Clin Cancer Res July 1 2011 17 (13) 4320-4330; DOI:10.1158/1078-0432.CCR-10-2992

  • Human Cancer Biology
    NGAL Expression Is Elevated in Both Colorectal Adenoma–Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse Models
    Yan Sun, Kenji Yokoi, Hui Li, Jun Gao, Limei Hu, Ben Liu, Kexin Chen, Stanley R. Hamilton, Dominic Fan, Baocun Sun and Wei Zhang
    Clin Cancer Res July 1 2011 17 (13) 4331-4340; DOI:10.1158/1078-0432.CCR-11-0226

  • Human Cancer Biology
    Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic Adenocarcinoma
    Audrey Vincent, Noriyuki Omura, Seung-Mo Hong, Andrew Jaffe, James Eshleman and Michael Goggins
    Clin Cancer Res July 1 2011 17 (13) 4341-4354; DOI:10.1158/1078-0432.CCR-10-3431

  • Human Cancer Biology
    FGFR-4 Arg388 Enhances Prostate Cancer Progression via Extracellular Signal–Related Kinase and Serum Response Factor Signaling
    Wendong Yu, Shu Feng, Olga Dakhova, Chad J. Creighton, Yi Cai, Jianghua Wang, Rile Li, Anna Frolov, Gustavo Ayala and Michael Ittmann
    Clin Cancer Res July 1 2011 17 (13) 4355-4366; DOI:10.1158/1078-0432.CCR-10-2858

  • Human Cancer Biology
    EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas
    Annett Hölsken, Matthias Gebhardt, Michael Buchfelder, Rudolf Fahlbusch, Ingmar Blümcke and Rolf Buslei
    Clin Cancer Res July 1 2011 17 (13) 4367-4377; DOI:10.1158/1078-0432.CCR-10-2811

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors
    Jessica K. Altman, Antonella Sassano, Surinder Kaur, Heather Glaser, Barbara Kroczynska, Amanda J. Redig, Suzanne Russo, Sharon Barr and Leonidas C. Platanias
    Clin Cancer Res July 1 2011 17 (13) 4378-4388; DOI:10.1158/1078-0432.CCR-10-2285

  • Cancer Therapy: Preclinical
    FGFR3 Is Overexpressed Waldenström Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation
    Abdel Kareem Azab, Feda Azab, Phong Quang, Patricia Maiso, Antonio Sacco, Hai T. Ngo, Yang Liu, Yong Zhang, Brittany L. Morgan, Aldo M. Roccaro and Irene M. Ghobrial
    Clin Cancer Res July 1 2011 17 (13) 4389-4399; DOI:10.1158/1078-0432.CCR-10-2772

  • Cancer Therapy: Preclinical
    Epidermal Growth Factor Receptor Inhibition Augments the Expression of MHC Class I and II Genes
    Brian P. Pollack, Bishu Sapkota and Todd V. Cartee
    Clin Cancer Res July 1 2011 17 (13) 4400-4413; DOI:10.1158/1078-0432.CCR-10-3283

  • Cancer Therapy: Preclinical
    Natura-Alpha Targets Forkhead Box M1 and Inhibits Androgen-Dependent and -Independent Prostate Cancer Growth and Invasion
    Yirong Li, Martin Ligr, James P. McCarron, Garrett Daniels, David Zhang, Xin Zhao, Fei Ye, Jinhua Wang, Xiaomei Liu, Iman Osman, Simon K. Mencher, Hebert Lepor, Long G. Wang and Peng Lee
    Clin Cancer Res July 1 2011 17 (13) 4414-4424; DOI:10.1158/1078-0432.CCR-11-0431

  • Cancer Therapy: Preclinical
    Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
    Hai Xu, Laura P. Stabile, Christopher T. Gubish, William E. Gooding, Jennifer R. Grandis and Jill M. Siegfried
    Clin Cancer Res July 1 2011 17 (13) 4425-4438; DOI:10.1158/1078-0432.CCR-10-3339

  • Cancer Therapy: Preclinical
    SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo
    Shuang Zhang, Zhixing Cao, Hongwei Tian, Guobo Shen, Yongping Ma, Huanzhang Xie, Yalin Liu, Chengjian Zhao, Senyi Deng, Yang Yang, Renlin Zheng, Weiwei Li, Na Zhang, Shengyong Liu, Wei Wang, Lixia Dai, Shuai Shi, Lin Cheng, Youli Pan, Shan Feng, Xia Zhao, Hongxin Deng, Shengyong Yang and Yuquan Wei
    Clin Cancer Res July 1 2011 17 (13) 4439-4450; DOI:10.1158/1078-0432.CCR-10-3109

  • Cancer Therapy: Preclinical | Free Article
    Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies
    Dana Faratian, Annelien J.M. Zweemer, Yoko Nagumo, Andrew H. Sims, Morwenna Muir, Michael Dodds, Peter Mullen, Inhwa Um, Charlene Kay, Max Hasmann, David J. Harrison and Simon P. Langdon
    Clin Cancer Res July 1 2011 17 (13) 4451-4461; DOI:10.1158/1078-0432.CCR-10-2461

  • Cancer Therapy: Preclinical
    The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary
    Seiji Mabuchi, Takeshi Hisamatsu, Chiaki Kawase, Masami Hayashi, Kenjiro Sawada, Kazuya Mimura, Kazuhiro Takahashi, Toshifumi Takahashi, Hirohisa Kurachi and Tadashi Kimura
    Clin Cancer Res July 1 2011 17 (13) 4462-4473; DOI:10.1158/1078-0432.CCR-10-2987

  • Cancer Therapy: Preclinical
    The Akt Inhibitor ISC-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model
    Arun K. Sharma, Christina L. Kline, Arthur Berg, Shantu Amin and Rosalyn B. Irby
    Clin Cancer Res July 1 2011 17 (13) 4474-4483; DOI:10.1158/1078-0432.CCR-10-2370

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
    Anne Kleijn, John W. Chen, Jason S. Buhrman, Gregory R. Wojtkiewicz, Yoshiko Iwamoto, Martine L. Lamfers, Anat O. Stemmer-Rachamimov, Samuel D. Rabkin, Ralph Weissleder, Robert L. Martuza and Giulia Fulci
    Clin Cancer Res July 1 2011 17 (13) 4484-4493; DOI:10.1158/1078-0432.CCR-11-0575

  • Imaging, Diagnosis, Prognosis
    An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA
    Shahnaz Begum, Mariana Brait, Santanu Dasgupta, Kimberly L. Ostrow, Marianna Zahurak, André L. Carvalho, Joseph A. Califano, Steven N. Goodman, William H. Westra, Mohammad Obaidul Hoque and David Sidransky
    Clin Cancer Res July 1 2011 17 (13) 4494-4503; DOI:10.1158/1078-0432.CCR-10-3436

  • Imaging, Diagnosis, Prognosis
    Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib
    Sandrine Faivre, Magaly Zappa, Valérie Vilgrain, Eveline Boucher, Jean-Yves Douillard, Ho Y. Lim, Jun S. Kim, Seock-Ah Im, Yoon-Koo Kang, Mohamed Bouattour, Safi Dokmak, Chantal Dreyer, Marie-Paule Sablin, Camille Serrate, Ann-Lii Cheng, Silvana Lanzalone, Xun Lin, Maria J. Lechuga and Eric Raymond
    Clin Cancer Res July 1 2011 17 (13) 4504-4512; DOI:10.1158/1078-0432.CCR-10-1708

  • Imaging, Diagnosis, Prognosis
    Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma
    Amin Ismail, Santhoshi Bandla, Marie Reveiller, Liana Toia, Zhongren Zhou, William E. Gooding, Irina Kalatskaya, Lincoln Stein, Mary D'Souza, Virginia R. Litle, Jeffrey H. Peters, Arjun Pennathur, James D. Luketich and Tony E. Godfrey
    Clin Cancer Res July 1 2011 17 (13) 4513-4522; DOI:10.1158/1078-0432.CCR-11-0244

  • Imaging, Diagnosis, Prognosis
    EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling
    Yong-June Kim, Hyung-Yoon Yoon, Seon-Kyu Kim, Young-Won Kim, Eun-Jung Kim, Isaac Yi Kim and Wun-Jae Kim
    Clin Cancer Res July 1 2011 17 (13) 4523-4530; DOI:10.1158/1078-0432.CCR-10-2817

  • Imaging, Diagnosis, Prognosis
    Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer
    Motofumi Tanaka, Ping Chang, Yanan Li, Donghui Li, Michael Overman, Dipen M. Maru, Salil Sethi, Jonathan Phillips, Gail L. Bland, James L. Abbruzzese and Cathy Eng
    Clin Cancer Res July 1 2011 17 (13) 4531-4540; DOI:10.1158/1078-0432.CCR-10-0763

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
    Sasja F. Mulder, Joannes F.M. Jacobs, Michel A.M. Olde Nordkamp, Joep M.D. Galama, Ingrid M.E. Desar, Ruurd Torensma, Steven Teerenstra, Peter F.A. Mulders, Kris C.P. Vissers, Cornelis J.A. Punt, I. Jolanda M. de Vries and Carla M.L. van Herpen
    Clin Cancer Res July 1 2011 17 (13) 4541-4549; DOI:10.1158/1078-0432.CCR-11-0253

  • Cancer Therapy: Clinical
    Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
    Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurencot, Seth M. Steinberg, Donald E. White and Mark E. Dudley
    Clin Cancer Res July 1 2011 17 (13) 4550-4557; DOI:10.1158/1078-0432.CCR-11-0116

  • Cancer Therapy: Clinical
    Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
    Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori A. Jones, Yi Xu, Jelle W. Kylstra and Mark W. Frohlich
    Clin Cancer Res July 1 2011 17 (13) 4558-4567; DOI:10.1158/1078-0432.CCR-10-3223

  • Cancer Therapy: Clinical
    Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
    Jon Amund Kyte, Gustav Gaudernack, Svein Dueland, Sissel Trachsel, Lars Julsrud and Steinar Aamdal
    Clin Cancer Res July 1 2011 17 (13) 4568-4580; DOI:10.1158/1078-0432.CCR-11-0184

Predictive Biomarkers and Personalized Medicine

  • Predictive Biomarkers and Personalized Medicine
    Multiple Loci Modulate Opioid Therapy Response for Cancer Pain
    Antonella Galvan, Frank Skorpen, Pål Klepstad, Anne Kari Knudsen, Torill Fladvad, Felicia S. Falvella, Alessandra Pigni, Cinzia Brunelli, Augusto Caraceni, Stein Kaasa and Tommaso A. Dragani
    Clin Cancer Res July 1 2011 17 (13) 4581-4587; DOI:10.1158/1078-0432.CCR-10-3028

  • Predictive Biomarkers and Personalized Medicine
    Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
    Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, Johannes Schramm, Oliver Schnell, Clemens Seidel, Robert Stein, Guido Reifenberger, Torsten Pietsch, Andreas von Deimling, Markus Loeffler and Michael Weller
    Clin Cancer Res July 1 2011 17 (13) 4588-4599; DOI:10.1158/1078-0432.CCR-10-3194

  • Predictive Biomarkers and Personalized Medicine
    Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
    Ji-Ye Yin, Jie Shen, Zi-Zheng Dong, Qiong Huang, Mei-Zuo Zhong, De-Yun Feng, Hong-Hao Zhou, Jian-Ting Zhang and Zhao-Qian Liu
    Clin Cancer Res July 1 2011 17 (13) 4600-4609; DOI:10.1158/1078-0432.CCR-10-2591

Letters to the Editor

  • Letters to the Editor
    Gefitinib versus Docetaxel for Previously Treated NSCLC—Letter
    Davide Tassinari, Luigi Lazzari-Agli, Paola Tombesi and Sergio Sartori
    Clin Cancer Res July 1 2011 17 (13) 4610-4610; DOI:10.1158/1078-0432.CCR-11-0125

  • Letters to the Editor
    Gefitinib versus Docetaxel for Previously Treated NSCLC—Response
    Dae Ho Lee and Sang-We Kim
    Clin Cancer Res July 1 2011 17 (13) 4611-4611; DOI:10.1158/1078-0432.CCR-11-0901

  • Letters to the Editor
    Modeling the Tumor Growth Profiles in Xenograft Experiments—Letter
    Ioannis D. Bassukas
    Clin Cancer Res July 1 2011 17 (13) 4612-4612; DOI:10.1158/1078-0432.CCR-11-0713

  • Letters to the Editor
    Modeling the Tumor Growth Profiles in Xenograft Experiments—Response
    Lili Zhao, Meredith A. Morgan, Leslie A. Parsels, Jonathan Maybaum, Theodore S. Lawrence and Daniel Normolle
    Clin Cancer Res July 1 2011 17 (13) 4613-4613; DOI:10.1158/1078-0432.CCR-11-0888

  • Letters to the Editor
    Clinical Trial Development as a Predictor of Accrual Performance—Letter
    Anneke T. Schroen
    Clin Cancer Res July 1 2011 17 (13) 4614-4614; DOI:10.1158/1078-0432.CCR-10-3418

  • Letters to the Editor
    Clinical Trial Development as a Predictor of Accrual Performance—Response
    Steven K. Cheng and David M. Dilts
    Clin Cancer Res July 1 2011 17 (13) 4615-4615; DOI:10.1158/1078-0432.CCR-11-0673

Back to top
PreviousNext
Clinical Cancer Research: 17 (13)
July 2011
Volume 17, Issue 13
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease
  • Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging
  • Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
  • EGFR Signaling Regulates Tumor Cell Migration in Craniopharyngiomas

Jump to

  • Highlights
  • CCR Translations
  • CCR New Strategies
  • Molecular Pathways
  • Review
  • Perspective
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Predictive Biomarkers and Personalized Medicine
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement